For 2018’s Good Deeds Day, employees at each Meridian site were given a cash stipend and a simple instruction: Go into your community and make a difference.
We were blown away by the thoughtfulness with which each Meridian site chose to donate to the community, support local charities, or perform small acts of kindness.
As we look forward to 2019 we want to thank the communities we serve. Here’s a recap of how we connected with our communities for Good Deeds Day 2018…
Evofem Biosciences, Inc. (NASDAQ: EVFM) (“Evofem” or the “Company”) today announced that its Phase 3 clinical trial of Amphora® for the prevention of pregnancy, AMPOWER, … Read more
Savannah, Ga., December 10, 2018 — Michael Hemphill, MD, has received the 2018 Health Professional Impact Award from the National Multiple Sclerosis Society (NMSS). He … Read more
Omaha, Neb., December 3, 2018 — Throughout the week of December 3-7, each Meridian Clinical Research location will celebrate a Good Deeds Day. This year’s … Read more
Omaha, Neb., October 24, 2018 — Meridian Clinical Research will attend the 19th World Vaccine Congress (WVC) in Lisbon, Portugal from October 29 to 31. As a leading investigative site network for vaccines and infectious diseases, Meridian will have several representatives at the conference.
Meridian recently sponsored its first golf event with Muscular Dystrophy Association (MDA) at the Tiburon Golf Club in Omaha, NE. The event raised almost $20,000 … Read more
Ellicott City, MD, September 25, 2018 – Today the Society for Clinical Research Sites (SCRS) announced the finalists for the 2018 Site Tank. Site Tank™ is a competition for sites to submit their innovative technology ideas that would enhance, empower and improve clinical research operations and transform business models.
Congratulations to the 2018 finalists: Amici Clinical Research, Envision Physician Clinical Research and Meridian Clinical Research.
The finalists will present their tech ideas at the Global Site Solutions Summit in Boca Raton, FL October 12-14, 2018. A judging panel made up of executives from the clinical research industry will select the winning presentation. [Meridian’s Andrew Kimball, VP, business development, will present on the topic of incorporating remote visits and data capture into clinical trials.]
Read moreMeridian Named an SCRS Global Summit Site Tank Finalist
SAVANNAH, GA. (PRWEB) SEPTEMBER 19, 2018 — Seven physicians and one physician assistant that serve as principal investigators for Meridian Clinical Research have won a ‘Best of Savannah Doctors 2018’ award. The award winners were determined by reader votes and are featured in the September/October issue of Savannah Magazine.
Read moreEight Meridian Investigators Voted ‘Best of Savannah’ by Savannah Magazine Readers
Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for … Read more
OMAHA, NEB., NORFOLK, NEB., AND SAVANNAH, GA. (PRWEB LINK) AUGUST 16, 2018
Results from clinical trials performed at Meridian Clinical Research sites in Norfolk, Neb., Omaha, Neb., and Savannah, Ga., were recently published in two prestigious medical journals.
Dr. Brandon Essink, Meridian’s medical director and principal investigator, co-authored an article published in Vaccine. Dr. Essink led a study at Meridian’s Omaha, Neb., site as part of a successful clinical trial for a vaccine found to provide broad protection against meningococcal disease (meningitis).